| Name | Sales (Cr) | Profit (Cr) | EBITDA (Cr) | Financial Year |
|---|---|---|---|---|
| ICRA | 342.81 | 113.53 | 161.46 | MAR, 2022 |
| CRISIL | 2,300.69 | 465.81 | 733.35 | DEC, 2021 |
| CARE Ratings | 248.45 | 90.97 | 127.07 | MAR, 2021 |
| Company | Market Cap (Cr) | Chg (%) | PE (x) | PB (x) | EV to Sales (x) | EV to EBITDA (x) | Dividend Yield (%) |
|---|---|---|---|---|---|---|---|
| CRISIL | 23,959.01 | -1.77 | 47.38 | 14.98 | 10.29 | 38.94 | 1.40 |
| ICRA | 3,776.29 | 0.16 | 34.46 | 4.49 | 10.17 | 29.21 | 0.72 |
| CARE Ratings | 1,423.15 | 1.99 | 18.31 | 2.25 | 4.60 | 12.38 | 2.08 |
i-Lens
